The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions
Official Title: The Efficacy and Safety of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Adhesions After Laparoscopic Gynecological Surgery: a Randomized Controlled Trial
Study ID: NCT02166554
Brief Summary: The purpose of this study was to determine whether the new crosslinked hyaluronan hydrogel was safe to use, and was effective for the prevention/reduction of adhesion formation following gynecological surgery
Detailed Description: Postsurgical adhesions are a common medical complication of gynecologic and pelvic surgeries, and are frequently associated with chronic or recurrent pelvic pain, intestinal obstruction and infertility. This randomized, controlled, multicenter, clinical study was designed to evaluate the safety and performance of the new crosslinked hyaluronan hydrogel versus the standard of care for the reduction of postoperative adhesions in subjects undergoing laparoscopic surgeries. Subjects were scheduled to return at 9 weeks after the initial surgical procedure. At that time, a second-look laparoscopy was performed for postsurgical adhesion assessment. Adhesions were graded using a modified American Fertility Society (mAFS) scoring system.
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Beijing Chao-Yang Hospital, Beijing, Beijing, China
China-Japan Friendship Hospital, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Beijing Hospital, Beijing, Beijing, China
The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
The Third Xiangya Hospital, Changsha, Hunan, China
Qilu Hospital, Jinan, Shandong, China
Name: Zhenyu Zhang, MD, PhD
Affiliation: Beijing Chao Yang Hospital
Role: PRINCIPAL_INVESTIGATOR